IMMUNGLOBULINFUSIONSPROTEINE

Patent europeic · EP3176264 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3176264
Numer da la dumonda
EP16206809
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-05-2008
Publitgà
07-06-2017
Concedì
26-09-2018
Stritgà
31-05-2019
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 15/62 (2006.01)
C07K 19/00 (2006.01)
C07K 16/46 (2006.01)
A61K 38/16 (2006.01)
A61K 38/00 (2006.01)
Prioritad
US 940753 P 30.05.2007
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-12-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 18.12.2019

  2. 26-09-2018

    Concedì

    Published in Swissreg on 26.09.2018

Partidas

Possessur

Postech Academy-Industry Foundation

Postech Academy-Industry- Foundation

San 31 Hyoja-dong, Pohang-city, Kyungbuk-do 790-784, KR

Genexine, Inc.

4th Fl., Bldg. B, Korea Bio Park Daewangpangyo-ro 700, Bundang-gu, Seongnam-si Gyeonggi-do 463-400, KR

Inventur

SUNG, Young Chul

Yongsan-gu, KR

YANG, Sehwan

Gyeonggi-do, KR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.